Multicentric Type 3 Gastric Neuroendocrine Tumors

다국어 초록 (Multilingual Abstract)

A 50-year-old woman with incidentally detected multiple gastric polyps and biopsy-proven neuroendocrine tumor (NET) was referred to our hospital. More than 10 polypoid lesions (less than 15 mm) with normal gastric mucosa were detected from the gastric body to the fundus. The serum level of gastrin was within the normal limits. There was no evidence of atrophic changes on endoscopy and serologic marker as pepsinogen I/II ratio. Computed tomography of the abdomen and pelvis revealed no evidence of metastatic lesions. She refused surgery, and we performed endoscopic polypectomy for almost all the gastric polyps that were greater than 5 mm. Although the histological examination revealed that all the removed polys were diagnosed as NET G1, three of them extended to the lateral or vertical resection margins, while two exhibited lymphovascular invasion. A follow-up upper endoscopy that was performed 6 months after the diagnosis showed multiple remnant gastric polyps that were suggestive of remnant gastric NET.

참고문헌 (Reference)

1 Fléjou JF, "WHO Classification of digestive tumors: the fourth edition" 31 : S27-S31, 2011

2 Merola E, "Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate" 95 : 207-213, 2012

3 Rindi G, "Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study" 104 : 994-1006, 1993

4 Lawrence B, "The epidemiology of gastroenteropancreatic neuroendocrine tumors" 40 : 1-18, 2011

5 Hassan MM, "Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study" 123 : 867-873, 2008

6 Basuroy R, "Review article: the investigation and management of gastric neuroendocrine tumours" 39 : 1071-1084, 2014

7 Thomas D, "Long-term follow- up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study" 168 : 185-193, 2013

8 Kwon YH, "Long-term follow up of endoscopic resection for type 3 gastric NET" 19 : 8703-8708, 2013

9 Bordi C, "Hypergastrinemia and gastric enterochromaffin-like cells" 19 (19): S8-S19, 1995

10 Delle Fave G, "Gastric neuroendocrine tumors" 80 (80): 16-19, 2004

11 Rindi G, "Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior" 20 : 168-172, 1996

12 Bordi C, "Gastric carcinoids" 31 (31): S94-S97, 1999

13 Spinelli P, "Endoscopic treatment of gastric carcinoids" 49 : 271-273, 1994

14 Delle Fave G, "ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms" 95 : 74-87, 2012

15 Katsinelos P, "Diffuse gastric carcinoid polyposis in multiple endocrine neoplasia 1 syndrome without hypergastrinemia" 66 : 411-412, 2007

16 Bordi C, "Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I" 21 : 1075-1082, 1997

17 Hosoya Y, "A case of multiple gastric carcinoids associated with multiple endocrine neoplasia type 1 without hypergastrinemia" 50 : 692-695, 1999

18 Moriyama T, "A case of multicentric gastric carcinoids without hypergastrinemia" 35 : 86-88, 2003

19 Modlin IM, "A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?" 99 : 23-32, 2004

20 Modlin IM, "A 5-decade analysis of 13,715 carcinoid tumors" 97 : 934-959, 2003